Bio-Path Holdings, Inc.
(NASDAQ : BPTH)

( )
BPTH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -4.58%55.070.0%$1467.11m
GILDGilead Sciences, Inc. -0.30%72.961.0%$1283.56m
AMGNAmgen, Inc. 0.10%222.631.3%$638.12m
NVAXNovavax, Inc. -0.06%48.14102.0%$608.29m
REGNRegeneron Pharmaceuticals, Inc. -2.61%531.002.5%$600.91m
VRTXVertex Pharmaceuticals, Inc. 0.14%266.861.9%$517.02m
BIIBBiogen, Inc. 2.08%302.021.6%$421.60m
ILMNIllumina, Inc. -0.25%353.533.5%$353.87m
SRNESorrento Therapeutics, Inc. 2.28%5.391.8%$314.05m
SGENSeattle Genetics, Inc. 0.84%153.006.1%$245.07m
ALXNAlexion Pharmaceuticals, Inc. 0.97%103.802.0%$226.24m
AAgilent Technologies, Inc. 1.37%86.141.6%$196.15m
CODXCo-Diagnostics, Inc. -1.28%17.800.0%$183.56m
MGNXMacroGenics, Inc. -2.92%22.956.2%$173.06m
BMRNBioMarin Pharmaceutical, Inc. 6.39%103.744.3%$172.63m

Company Profile

Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.